Return to Work After Varicella with Acyclovir Treatment
An adult with varicella who started oral acyclovir can return to work when all lesions have crusted over, regardless of acyclovir treatment, as the medication does not reduce viral transmission or shorten the infectious period.
Key Evidence on Acyclovir and Transmission
The critical finding from ACIP guidelines is unequivocal: administration of acyclovir did not decrease transmission of varicella or reduce the duration of absence from school 1. This is the definitive answer to your question - acyclovir treatment does not change the return-to-work timeline.
Standard Return-to-Work Criteria
The infectious period for varicella extends from 1-2 days before rash onset until all lesions have crusted over. This typically occurs:
- 5-7 days after rash onset in untreated adults
- Potentially 5.6 days in adults treated with acyclovir within 24 hours of rash onset (versus 7.4 days untreated) 2
However, this shortened crusting time does not translate to earlier return to work from an infection control standpoint, as viral shedding patterns remain unchanged by oral acyclovir therapy.
Clinical Context of Acyclovir Benefits
While acyclovir reduces symptom severity and duration when started within 24 hours of rash onset 1, 2, these benefits are purely clinical:
- Decreased fever duration
- Reduced number of lesions
- Less severe symptoms
- Faster cutaneous healing
Treatment initiated after 24 hours of rash onset provides no clinical benefit 2, 3, 4.
Practical Return-to-Work Algorithm
- Inspect all skin lesions - every single lesion must be crusted (dry, scabbed over)
- No new vesicles - confirm no new fluid-filled lesions are appearing
- Typically 5-7 days from rash onset in most adults
- Immunocompromised patients - may require longer isolation regardless of acyclovir use
Critical Pitfall to Avoid
Do not allow patients to return to work early simply because they are on acyclovir. The medication improves how they feel but does not reduce their contagiousness. The virus remains transmissible until complete crusting occurs, and acyclovir does not accelerate this from an infectious disease standpoint, despite potentially faster clinical healing 1.
Special Considerations
For immunocompromised adults, intravenous acyclovir is indicated and isolation periods may be extended beyond standard timelines 1. For pregnant contacts or other high-risk exposures in the workplace, ensure proper assessment of immunity status before the patient returns.
The bottom line: All lesions crusted = fit to return to work, whether or not acyclovir was used.